Wed, Dec 24, 2014, 8:06 PM EST - U.S. Markets closed early today


% | $
Quotes you view appear here for quick access.

Neostem, Inc. Message Board

kwood1764 2 posts  |  Last Activity: Nov 16, 2014 6:56 AM Member since: Oct 21, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • kwood1764 by kwood1764 Nov 16, 2014 6:56 AM Flag

    For those of us who have been with NBS for quite a while, that read MB's but rarely post and perhaps are irresponsible dreamers (don't let anyone tell you thats a bad thing) I offer very rare stock gains in recent history that could be the ride ahead...

    We remember SRPT a Cramer recommended speculative bio stock
    - Sarepta has the only treatment for a very rare genetic and degenerative disease called Duchenne Muscular Dystrophy - that shot up to the stratosphere on Oct 3, 2012 rising 200% in a single session.

    We also know that Puma Biotechnology Inc. (NASDAQ: PBYI) a development stage biopharmaceutical company gain 260% in one day in July this summer is up 400% this year after being up 400% last year...

    Or the Lannett Company -up about 500% - which began to trade on the New York Stock Exchange on December 13, 2013 (sound familiar) Lannett, develops, manufactures, packages, markets and distributes generic pharmaceutical products

    I'm in no way suggesting that will happen to us, but as we know from
    CELG and others it's not like it's never happened before...Be interesting to watch the lead up on Monday and 9:31 on Tuesday morning


  • kwood1764 by kwood1764 Nov 11, 2014 8:41 PM Flag

    Conference Presentation after market closes...
    Press--conference before market opens....
    Conference presentation before market opens....

    It's either really good.... or really.....

    Cue up 9:30a market open on 18th....

    Good Luck

3.27+0.02(+0.62%)Dec 24 1:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.